Skip to main content
Log in

Generics cost saving for Medicare beneficiaries

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Patel RA, et al. Cost variability of suggested generic treatment alternatives under the medicare part d benefit. Journal of Managed Care Pharmacy 20: 283-90, No. 4, Mar 2014. Available from: URL: http://dx.doi.org2014(20)4: 283-290 [pii]

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Generics cost saving for Medicare beneficiaries. PharmacoEcon Outcomes News 699, 6 (2014). https://doi.org/10.1007/s40274-014-1138-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1138-y

Navigation